Bionano Genomics, Inc. (BNGO)
USD 2.83
(-4.07%)
USD 2.83
(-4.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 22.89 Million USD | -23.08% |
| 2022 | 29.76 Million USD | 140.26% |
| 2021 | 12.38 Million USD | 273.59% |
| 2020 | 3.31 Million USD | -3.71% |
| 2019 | 3.44 Million USD | 222.26% |
| 2018 | 1.06 Million USD | -36.91% |
| 2017 | 1.69 Million USD | -5.77% |
| 2016 | 1.79 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 19.47 Million USD | -0.57% |
| 2024 Q1 | 19.58 Million USD | -14.44% |
| 2023 Q3 | 26.42 Million USD | -18.56% |
| 2023 FY | 22.89 Million USD | -23.08% |
| 2023 Q4 | 22.89 Million USD | -13.38% |
| 2023 Q2 | 32.45 Million USD | -1.99% |
| 2023 Q1 | 33.11 Million USD | 11.26% |
| 2022 FY | 29.76 Million USD | 140.26% |
| 2022 Q3 | 25.04 Million USD | 21.64% |
| 2022 Q2 | 20.59 Million USD | 26.57% |
| 2022 Q1 | 16.26 Million USD | 31.33% |
| 2022 Q4 | 29.76 Million USD | 18.83% |
| 2021 FY | 12.38 Million USD | 273.59% |
| 2021 Q2 | 4.89 Million USD | 61.07% |
| 2021 Q3 | 9.02 Million USD | 84.46% |
| 2021 Q4 | 12.38 Million USD | 37.33% |
| 2021 Q1 | 3.03 Million USD | -8.44% |
| 2020 Q3 | 4.59 Million USD | 39.6% |
| 2020 Q1 | 3.61 Million USD | 4.86% |
| 2020 Q4 | 3.31 Million USD | -27.81% |
| 2020 FY | 3.31 Million USD | -3.71% |
| 2020 Q2 | 3.29 Million USD | -8.89% |
| 2019 FY | 3.44 Million USD | 222.26% |
| 2019 Q4 | 3.44 Million USD | 32.69% |
| 2019 Q3 | 2.59 Million USD | -14.13% |
| 2019 Q2 | 3.02 Million USD | 114.97% |
| 2019 Q1 | 1.4 Million USD | 31.56% |
| 2018 Q3 | 2.61 Million USD | 32.53% |
| 2018 FY | 1.06 Million USD | -36.91% |
| 2018 Q4 | 1.06 Million USD | -59.13% |
| 2018 Q1 | 2.01 Million USD | 18.91% |
| 2018 Q2 | 1.97 Million USD | -2.04% |
| 2017 Q4 | 1.69 Million USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 1.69 Million USD | -5.77% |
| 2016 FY | 1.79 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | -6836.705% |
| Aspira Women's Health Inc. | 227 Thousand USD | -9985.022% |
| Biodesix, Inc. | 1.4 Million USD | -1535.214% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | -1912.094% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -123753.062% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -123753.062% |
| CareDx, Inc | 19.47 Million USD | -17.575% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 7.94 Million USD | -188.252% |
| DarioHealth Corp. | 5.06 Million USD | -352.252% |
| Exact Sciences Corporation | 127.47 Million USD | 82.041% |
| Fulgent Genetics, Inc. | 5.82 Million USD | -292.878% |
| Guardant Health, Inc. | 61.94 Million USD | 63.045% |
| ICON Public Limited Company | 1.00 USD | -2289299900.0% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 93.98% |
| Illumina, Inc. | 587 Million USD | 96.1% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -2844.297% |
| iSpecimen Inc. | - USD | -Infinity% |
| Standard BioTools Inc. | 20.53 Million USD | -11.494% |
| MDxHealth SA | 2.77 Million USD | -723.786% |
| 23andMe Holding Co. | 12.46 Million USD | -83.658% |
| Medpace Holdings, Inc. | 1.00 USD | -2289299900.0% |
| Myriad Genetics, Inc. | 20.1 Million USD | -13.896% |
| Mainz Biomed B.V. | 613.63 Thousand USD | -3630.701% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | -772.824% |
| NeoGenomics, Inc. | 24.15 Million USD | 5.229% |
| Neogen Corporation | 189.26 Million USD | 87.904% |
| Inotiv, Inc. | 56.1 Million USD | 59.194% |
| Natera, Inc. | 40.75 Million USD | 43.833% |
| OpGen, Inc. | 1.00 USD | -2289299900.0% |
| OPKO Health, Inc. | 65.69 Million USD | 65.154% |
| Psychemedics Corporation | 1.00 USD | -2289299900.0% |
| Prenetics Global Limited | 3.12 Million USD | -632.16% |
| Prenetics Global Limited | 3.12 Million USD | -632.16% |
| Precipio, Inc. | 384 Thousand USD | -5861.719% |
| Personalis, Inc. | 5.66 Million USD | -304.399% |
| RadNet, Inc. | 1.00 USD | -2289299900.0% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| Sotera Health Company | 51.98 Million USD | 55.962% |
| Neuronetics, Inc. | 8.09 Million USD | -182.874% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -569.386% |
| Star Equity Holdings, Inc. | 3.42 Million USD | -569.386% |
| Trinity Biotech plc | 19.93 Million USD | -14.85% |
| T2 Biosystems, Inc. | 4.81 Million USD | -375.057% |
| Twist Bioscience Corporation | 32.06 Million USD | 28.6% |
| Exagen Inc. | 2.87 Million USD | -697.388% |